Precipio, Inc. (PRPO) Stock

Precipio, Inc. (PRPO) is a Technology stock trading at $22.66 (as of 2026-06-18), with a market capitalization of $42.49M and a trailing P/E of -49.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Precipio, Inc. provides diagnostic products, reagents, and services for blood cancer and other diagnostic testing in the United States. Its offerings include cell culture media (IV-Cell), genetic diagnostic panels (HemeScreen), specimen technology for molecular tests (ICE-COLD PCR), and antibody tests, with technology kits sold to biopharma customers and additional services for diagnostic testing providers.

Valuation — source: SEC EDGAR (first-party)
Price	$22.66
Market Cap	$42.49M
P/E Ratio	-49.9
EV / EBITDA	-66.0
Price / Book	2.83
Price / Sales	1.55
DCF Value (model)	$4.87
DCF Upside vs Price	-78.5%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$24.05M
Net Margin	-1.5%
Return on Equity	-6.5%
Debt / Equity	0.00
Current Ratio	1.56
Revenue Growth (YoY)	36.2%
EPS Growth (YoY)	37.3%
FCF Growth (YoY)	-107.7%

Financial Health — source: SEC EDGAR
Altman Z-Score	-2.09 (distress)
Piotroski F-Score	7/9 (strong)

Valuation vs Sector & Industry
Stock P/E	-49.9
Sector P/E (Technology)	32.6
Industry P/E (Measuring & Control Equipment)	60.1
vs Sector	-252.8%
vs Industry	-183.0%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock, Inc. ($725550.00)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Measuring & Control Equipment
CEO	Ilan Danieli
Employees	54
Country	US
IPO Date	2017-06-30

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.